SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-014880
Filing Date
2021-03-23
Accepted
2021-03-23 16:38:12
Documents
15
Period of Report
2021-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-8k_20210319.htm   iXBRL 8-K 42736
2 EX-10.1 bdsx-ex101_29.htm EX-10.1 395641
3 EX-99.1 bdsx-ex991_30.htm EX-99.1 10516
4 GRAPHIC gfxxa2aurhv5000001.jpg GRAPHIC 2857
  Complete submission text file 0001564590-21-014880.txt   675322

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20210319.xsd EX-101.SCH 5760
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20210319_lab.xml EX-101.LAB 20220
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20210319_pre.xml EX-101.PRE 12074
8 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-8k_20210319_htm.xml XML 3687
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 21765251
SIC: 8071 Services-Medical Laboratories